-
1
-
-
0024166189
-
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: A preliminary report
-
Rosenberg SA, Packard BS, Aebersold PM: Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report. New England J Med 25: 319-323, 1988.
-
(1988)
New England J Med
, vol.25
, pp. 319-323
-
-
Rosenberg, S.A.1
Packard, B.S.2
Aebersold, P.M.3
-
2
-
-
0025330178
-
Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies
-
Atzpodien J, Korfer A, Franks CR, Poliwoda H, Kirchner H: Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies. Lancet 335: 1509-1512, 1990.
-
(1990)
Lancet
, vol.335
, pp. 1509-1512
-
-
Atzpodien, J.1
Korfer, A.2
Franks, C.R.3
Poliwoda, H.4
Kirchner, H.5
-
3
-
-
0025194233
-
Immune responses in humans while receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells: Acute anergy to mitogens and recall antigens
-
Ades E W, Bosse D, Orr S, Gillespie T: Immune responses in humans while receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells: acute anergy to mitogens and recall antigens. Pathobiol 58: 78-83, 1990.
-
(1990)
Pathobiol
, vol.58
, pp. 78-83
-
-
Ades, E.W.1
Bosse, D.2
Orr, S.3
Gillespie, T.4
-
4
-
-
0025633477
-
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients. I. Phenotypic and functional analysis of the peripheral blood mononuclear cells
-
Fortis C, Ferrero E, Besana C, Biffi M, Heltai S, Galli L, Borri A, Schoenheit A, Rugarli C: Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients. I. Phenotypic and functional analysis of the peripheral blood mononuclear cells. Cancer Immunol Immunother 32: 161-166, 1990.
-
(1990)
Cancer Immunol Immunother
, vol.32
, pp. 161-166
-
-
Fortis, C.1
Ferrero, E.2
Besana, C.3
Biffi, M.4
Heltai, S.5
Galli, L.6
Borri, A.7
Schoenheit, A.8
Rugarli, C.9
-
5
-
-
0023874674
-
The in vitro function of lymphocytes from 25 cancer patients receiving four to seven consecutive days of recombinant IL-2
-
Rosenthal NS, Hank JA, Kolher PC, Minkoff DZ, Moore KH, Bechhofer R, Hong R, Storer B, Sondel PM: The in vitro function of lymphocytes from 25 cancer patients receiving four to seven consecutive days of recombinant IL-2. J Biol Response Mod 7: 123-139, 1988.
-
(1988)
J Biol Response Mod
, vol.7
, pp. 123-139
-
-
Rosenthal, N.S.1
Hank, J.A.2
Kolher, P.C.3
Minkoff, D.Z.4
Moore, K.H.5
Bechhofer, R.6
Hong, R.7
Storer, B.8
Sondel, P.M.9
-
6
-
-
0024264288
-
Acute immunologic effects of interleukin-2 therapy in cancer patients: Decreased delayed -type hypersensitivity response and decreased proliferative response to soluble antigens
-
Wiebke EA, Rosenberg SA, Lotze MT,: Acute immunologic effects of interleukin-2 therapy in cancer patients: decreased delayed -type hypersensitivity response and decreased proliferative response to soluble antigens. J Clin Oncol 6: 1440-1449, 1988.
-
(1988)
J Clin Oncol
, vol.6
, pp. 1440-1449
-
-
Wiebke, E.A.1
Rosenberg, S.A.2
Lotze, M.T.3
-
7
-
-
85069081545
-
Research of the optimal dose of interleukin-2 for the selective growth in vitro of lymphocytes with anti-tumoral cytolitic activity
-
Capelli E, Nano R, Asti M, Lavezzi L, Rossi A, Cuccia M, Salvucci O. Gerzeli G: Research of the optimal dose of interleukin-2 for the selective growth in vitro of lymphocytes with anti-tumoral cytolitic activity. Europ J Histochem 375: 18, 1993.
-
(1993)
Europ J Histochem
, vol.375
, pp. 18
-
-
Capelli, E.1
Nano, R.2
Asti, M.3
Lavezzi, L.4
Rossi, A.5
Cuccia, M.6
Salvucci, O.7
Gerzeli, G.8
-
8
-
-
0030324738
-
Morphological changes of lymphocytes activated with interleukin-2
-
Nano R, Barni S, Capelli E : Morphological changes of lymphocytes activated with interleukin-2. Haematologica 81: 93-94, 1996.
-
(1996)
Haematologica
, vol.81
, pp. 93-94
-
-
Nano, R.1
Barni, S.2
Capelli, E.3
-
9
-
-
0026017971
-
Interleukin-2 programs mouse ab T lymphocytes for apoptosis
-
Lenardo MJ: Interleukin-2 programs mouse ab T lymphocytes for apoptosis. Nature 353: 858-861, 1991.
-
(1991)
Nature
, vol.353
, pp. 858-861
-
-
Lenardo, M.J.1
-
10
-
-
0025770075
-
Accumulation of adoptively transferred adherent lymphokine-activated killer cells in murine metastases
-
Basse F, Herberman RB, Nannmark U, Johansson BR, Hokland M, Wasserman K, Goldfarb RH: Accumulation of adoptively transferred adherent lymphokine-activated killer cells in murine metastases. J Exp Med 174: 479-488, 1991.
-
(1991)
J Exp Med
, vol.174
, pp. 479-488
-
-
Basse, F.1
Herberman, R.B.2
Nannmark, U.3
Johansson, B.R.4
Hokland, M.5
Wasserman, K.6
Goldfarb, R.H.7
-
11
-
-
0024367332
-
In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma
-
Griffith KD, Read EJ, Carrasquillo JA, Carter CS, Yang JC, Fisher B, Aebersold P, Packard BS, Yu MY, Rosenberg SA: In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma. J Natl Cancer Inst 81: 1709-1717, 1989.
-
(1989)
J Natl Cancer Inst
, vol.81
, pp. 1709-1717
-
-
Griffith, K.D.1
Read, E.J.2
Carrasquillo, J.A.3
Carter, C.S.4
Yang, J.C.5
Fisher, B.6
Aebersold, P.7
Packard, B.S.8
Yu, M.Y.9
Rosenberg, S.A.10
-
12
-
-
0010588842
-
Interleukin-2 enhances T lymphocyte migration to the tumor site
-
Janssen R, Jongsma J, Noteboom J, Kroesen BJ, Helfrich W, Kal H, The H, De Leij: Interleukin-2 enhances T lymphocyte migration to the tumor site. Proc Am Assoc Cancer Res 34:486, 1993.
-
(1993)
Proc Am Assoc Cancer Res
, vol.34
, pp. 486
-
-
Janssen, R.1
Jongsma, J.2
Noteboom, J.3
Kroesen, B.J.4
Helfrich, W.5
Kal, H.6
The, H.7
De Leij8
-
14
-
-
0025965167
-
Receptor-stimulated death pathway is opened by antigen in mature T cells
-
Russel JH, White CL, Loh DY, Meleedy-Rey P: Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci USA 88: 2151-2155, 1991.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 2151-2155
-
-
Russel, J.H.1
White, C.L.2
Loh, D.Y.3
Meleedy-Rey, P.4
-
15
-
-
0027315279
-
Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells
-
Wesselborg S, Janssen O, Kabelitz DJ: Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 150: 4388-4345, 1993.
-
(1993)
J Immunol
, vol.150
, pp. 4388-14345
-
-
Wesselborg, S.1
Janssen, O.2
Kabelitz, D.J.3
-
16
-
-
0026672306
-
Activation-driven cell death II. Quantitative differences alone distinguish stimuli triggering non transformed T cell proliferation or death
-
Ucker D, Meyers J, Obermiller PS: Activation-driven cell death II. Quantitative differences alone distinguish stimuli triggering non transformed T cell proliferation or death. J Immunol 149: 1583-1592. 1992.
-
(1992)
J Immunol
, vol.149
, pp. 1583-1592
-
-
Ucker, D.1
Meyers, J.2
Obermiller, P.S.3
|